Metis Global Partners LLC Has $7.27 Million Stake in Danaher Corporation $DHR

Metis Global Partners LLC lessened its stake in Danaher Corporation (NYSE:DHR) by 18.5% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 36,790 shares of the conglomerate’s stock after selling 8,378 shares during the period. Metis Global Partners LLC’s holdings in Danaher were worth $7,267,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently made changes to their positions in DHR. Pacific Capital Partners Ltd bought a new stake in shares of Danaher during the 1st quarter valued at $7,175,000. Cerity Partners LLC grew its holdings in shares of Danaher by 11.8% in the 1st quarter. Cerity Partners LLC now owns 337,409 shares of the conglomerate’s stock valued at $69,170,000 after buying an additional 35,712 shares during the period. Ramsay Stattman Vela & Price Inc. increased its position in shares of Danaher by 1.2% in the 1st quarter. Ramsay Stattman Vela & Price Inc. now owns 68,912 shares of the conglomerate’s stock valued at $14,127,000 after buying an additional 803 shares in the last quarter. Robeco Schweiz AG lifted its holdings in Danaher by 26.0% during the first quarter. Robeco Schweiz AG now owns 327,058 shares of the conglomerate’s stock worth $67,047,000 after acquiring an additional 67,513 shares in the last quarter. Finally, Diversify Wealth Management LLC increased its holdings in shares of Danaher by 25.3% in the first quarter. Diversify Wealth Management LLC now owns 10,254 shares of the conglomerate’s stock worth $2,040,000 after acquiring an additional 2,068 shares in the last quarter. Institutional investors own 79.05% of the company’s stock.

Wall Street Analysts Forecast Growth

DHR has been the topic of several research analyst reports. Wells Fargo & Company restated a “positive” rating on shares of Danaher in a report on Thursday, October 23rd. Cowen restated a “buy” rating on shares of Danaher in a report on Wednesday, October 22nd. JPMorgan Chase & Co. upped their target price on shares of Danaher from $260.00 to $270.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 22nd. Weiss Ratings reissued a “hold (c-)” rating on shares of Danaher in a research note on Wednesday, October 8th. Finally, Guggenheim restated a “buy” rating and issued a $250.00 price target on shares of Danaher in a report on Wednesday, July 23rd. Eighteen investment analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $243.39.

Danaher Price Performance

DHR stock opened at $209.89 on Friday. The stock has a market cap of $148.26 billion, a price-to-earnings ratio of 43.28, a P/E/G ratio of 3.28 and a beta of 0.81. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.52 and a quick ratio of 1.10. The company has a 50 day simple moving average of $204.02 and a 200 day simple moving average of $200.32. Danaher Corporation has a 1 year low of $171.00 and a 1 year high of $258.23.

Danaher (NYSE:DHR) last posted its earnings results on Tuesday, October 21st. The conglomerate reported $1.89 earnings per share for the quarter, topping analysts’ consensus estimates of $1.72 by $0.17. Danaher had a net margin of 14.44% and a return on equity of 10.92%. The firm had revenue of $6.05 billion for the quarter, compared to analysts’ expectations of $6 billion. The company’s revenue was up 4.4% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.71 earnings per share. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. Research analysts anticipate that Danaher Corporation will post 7.63 EPS for the current fiscal year.

Danaher Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, October 31st. Stockholders of record on Friday, September 26th were paid a $0.32 dividend. The ex-dividend date of this dividend was Friday, September 26th. This represents a $1.28 annualized dividend and a dividend yield of 0.6%. Danaher’s dividend payout ratio is currently 26.39%.

Insider Transactions at Danaher

In related news, Director Teri List sold 2,778 shares of Danaher stock in a transaction that occurred on Friday, August 22nd. The shares were sold at an average price of $211.06, for a total transaction of $586,324.68. Following the sale, the director directly owned 20,751 shares in the company, valued at $4,379,706.06. This trade represents a 11.81% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 11.10% of the stock is currently owned by company insiders.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.